Literature DB >> 11746060

Preferences for care near the end of life: scale development and validation.

D M Gauthier1, R D Froman.   

Abstract

The purpose of this study was to develop and validate an instrument, the Preferences for Care near the End of Life (PCEOL) scale. Following a literature review and using the domain-referenced approach and a test grid, a large pool of items was generated to reflect five dimensions of preferences for care near the end of life. These were reviewed for relevance and clarity by an expert panel. A convenience sample of 198 adults was secured to provide data for the study of the psychometric properties of the scale. Data screening and item analysis resulted in a final sample of 43 items. A principal factor analysis (PFA) resulted in an interpretable, meaningful five-factor solution. Reliability estimates (internal consistency) for the factors on the multidimensional instrument ranged from.68 to.91. Retest stability estimates for the PCEOL showed correlations of.80 to.94 for factor scores over a 2-week interval. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  2001        PMID: 11746060     DOI: 10.1002/nur.1031

Source DB:  PubMed          Journal:  Res Nurs Health        ISSN: 0160-6891            Impact factor:   2.228


  3 in total

1.  Development of an evidence-based protocol for care of pilonidal sinus wounds healing by secondary intent using a modified Reactive Delphi procedure. Part 2: methodology, analysis and results.

Authors:  Connie L Harris; Samantha Holloway
Journal:  Int Wound J       Date:  2012-02-02       Impact factor: 3.315

Review 2.  Review of measurement instruments in clinical and research ethics, 1999-2003.

Authors:  B K Redman
Journal:  J Med Ethics       Date:  2006-03       Impact factor: 2.903

3.  Evaluation and ethical review of a tool to explore patient preferences for information and involvement in decision making.

Authors:  F E M Murtagh; A Thorns
Journal:  J Med Ethics       Date:  2006-06       Impact factor: 2.903

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.